Survival Rate Following Trans Metatarsal Amputation: A Five-Year Retrospective Review

Georgeanne Botek, Fernando Cruz, Christopher Tulodzieski and Tammy Owings Deng

Department of Podiatry, Mercy Regional Medical Center, USA
Department of Podiatry, Cleveland Clinic Foundation, USA

^*Correspondance to: Georgeanne Botek 

 PDF  Full Text DOI: 10.25107/2474-1647.1550

Abstract

Background: The aim of this study is to examine the five-year mortality rate, after a Tran’s metatarsal amputation (TMA), in comparison to reported mortality rates of a below-knee amputation (BKA). This study also analyzes disease(s) that increase mortality.Methods: The records of patients who underwent TMA at the Cleveland Clinic by podiatric surgery between 2009 to 2011 were retrospectively reviewed. Records were evaluated for mortality status, age, and co-morbidities.Results: A total of 129 post-TMA patients were investigated, 90 males (69.7%) and 39 females (30.2%) with the mean age of 62 (20-91). Of 129 patients, 54 were deceased (41.8%), with 33% of the population expiring within the first 12 months of the TMA. Co-morbidities included diabetes (79%), hypertension (90%), PVD (53%), CAD (36%), previous foot amputation (30%), neuropathy (68%), and renal disease (45%). Compared to the other diseases, there were more deceased patients who suffered from renal diseases (57%).Conclusion: Following TMA procedure, there is a 39%, 5-year mortality rate, compared to 40% to 82%, after BKA. This demonstrates the differences in mortality of major versus minor limb amputation, with TMAs increasing patient longevity. Thus, this limb salvage procedure should be considered when applicable. Also, mortality in patients with renal disease was higher compared to other diseases.

Keywords

Tran’s metatarsal amputation; Mortality; HTN; PVD

Cite the article

Botek G, Cruz F, Tulodzieski C, Deng TO. Survival Rate Following Trans Metatarsal Amputation: A Five-Year Retrospective Review. Clin Surg. 2017; 2: 1550.